Renata Zaucha - Concepedia

Author

Renata Zaucha

Also Known As

Anna Polakiewicz-Gilowska, Krzysztof Tupikowski, R Zaucha, R. Zaucha, R.E. Zaucha, Renata E Zaucha, Renata E. Zaucha, Renata Zaucha, Robert Kozłowski, Zaucha, Renata; Katedra i Klinika Onkologii i Radioterapii Akademii Medycznej w Gdańsku

107

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Gdańsk Medical University Nanjing General Hospital of Nanjing Military Command Fred Hutch Cancer Center Hôpital Beaujon Sarah Cannon

About

Renata Zaucha is an author at Gdańsk Medical University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.8K
2	Health Sciences	5	5	1.3K
3	Immunology	3	3	280
4	Gastroenterology	2	2	106
5	Orthopaedics	1	1	18

Renata Zaucha

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer Do‐Youn Oh, Aiwu Ruth He, Shukui Qin, NEJM Evidence Placebo MonotherapyHealth SciencesGastrointestinal OncologyMedicineCancer Management	2022	986
A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1. Do‐Youn Oh, Aiwu Ruth He, Shukui Qin, Journal of Clinical Oncology ImmunologyPathologyImmunotherapeuticsImmunotherapyOncology	2022	230
CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation Jan Maciej Zaucha, Theodore A. Gooley, William Bensinger, Blood	2001	226
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study Do‐Youn Oh, Aiwu Ruth He, Mohamed Bouattour, The Lancet. Gastroenterology & hepatology Overall SurvivalGastrointestinal OncologyMedicineRandomised Phase 3Biliary Cancer	2024	196
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network Damien C. Weber, Yucai Wang, Robert C. Miller, Neuro-Oncology	2014	122
The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer Network Alessia Pica, Robert C. Miller, S. Villà, International Journal of Radiation OncologyBiologyPhysics Retrospective StudySurgical OncologyRare Cancer NetworkMedicineSurgical Pathology	2009	114
Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study Jaffer A. Ajani, Marc Buyse, Mikhail Lichinitser, European Journal of Cancer Safety AnalysesEsophageal CancerGastrointestinal OncologyGastroesophageal AdenocarcinomaMedicine	2013	83
The Essential Role of Radiotherapy in the Treatment of Merkel Cell Carcinoma: A Study From the Rare Cancer Network Pirus Ghadjar, Johannes H.A.M. Kaanders, P. Poortmans, International Journal of Radiation OncologyBiologyPhysics Rare Cancer NetworkEssential RoleRadiation TherapyMedicineBrachytherapy	2011	73
BRCA1 and BRCA2 Mutations in Women from Shanghai China Nicola M. Suter, Roberta M. Ray, Yong Wei Hu, Cancer Epidemiology Biomarkers & Prevention	2004	73
Chemotherapy-Related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients with, or without, High Protein Nutritional Support. A Prospective, Randomized Study Monika Ziętarska, Joanna Krawczyk-Lipiec, Leszek Kraj, Nutrients	2017	65

Page 1